+ Watch ARIA
on My Watchlist
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
IBD EPS, RS, SPROE, Acc ratings plus P/E and div yieldMEDICAL 5 95 DB NEG EARNINGS
24 59 DB- no earnings. Still hate it, keep selling.
24 15 DE, parity, close.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions